These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2148226)
1. t-PA activity elicited by venous occlusion or DDAVP infusion does not produce plasmin activity in normal subjects. Cugno M; Uziel L; Marongiu F; Bottasso B; Legnani C; Palareti G Thromb Res; 1990 Sep; 59(6):1007-11. PubMed ID: 2148226 [No Abstract] [Full Text] [Related]
2. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion. Keber D; Stegnar M; Kluft C Thromb Haemost; 1990 Feb; 63(1):72-5. PubMed ID: 2111049 [TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion. Cugno M; Uziel L; Fabrizi I; Bottasso B; Maggiolini F; Agostoni A Thromb Res; 1989 Dec; 56(5):625-34. PubMed ID: 2516662 [TBL] [Abstract][Full Text] [Related]
4. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion. Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease. Duprez D; Baele G; De Buyzere M; Vandenbroecke P; Clement DL Eur Heart J; 1991 Jul; 12(7):800-2. PubMed ID: 1909628 [TBL] [Abstract][Full Text] [Related]
6. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients. Sultan Y; Harris A; Strauch G; Venot A; De Lauture D J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470 [TBL] [Abstract][Full Text] [Related]
8. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599 [TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin. Rudd MA; Johnstone MT; Rabbani LE; George D; Ware JA; Loscalzo J Circulation; 1991 Dec; 84(6):2568-73. PubMed ID: 1835680 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Levi M; de Boer JP; Roem D; ten Cate JW; Hack CE Thromb Haemost; 1992 Jan; 67(1):111-6. PubMed ID: 1377412 [TBL] [Abstract][Full Text] [Related]
11. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states. Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814 [TBL] [Abstract][Full Text] [Related]
12. Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarism. Juhan-Vague I; Conte-Devolx B; Aillaud MF; Mendez C; Oliver C; Collen D Thromb Res; 1984 Mar; 33(6):653-9. PubMed ID: 6609451 [No Abstract] [Full Text] [Related]
13. A comparative study of venous occlusion and DDAVP stimulated fibrinolysis in normolipidemic subjects. Smith P; Arnesen H; Dahl KH; Nilsen DW; Opstad T; Andersen P Thromb Res; 1988 Dec; 52(6):655-60. PubMed ID: 3148209 [No Abstract] [Full Text] [Related]
14. Additive effect of dDAVP and standard heparin in increasing plasma t-PA. Agnelli G; Levi M; Cosmi B; ten Cate JW; Nenci GG Thromb Haemost; 1989 Jun; 61(3):507-10. PubMed ID: 2508260 [TBL] [Abstract][Full Text] [Related]
16. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma. Huisman LG; van Griensven JM; Kluft C Thromb Haemost; 1995 Mar; 73(3):466-71. PubMed ID: 7667830 [TBL] [Abstract][Full Text] [Related]
17. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA Nephron; 1990; 54(4):322-6. PubMed ID: 2109264 [TBL] [Abstract][Full Text] [Related]
19. DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects. Marasini B; Cugno M; Bassani C; Fabrizi I; Bottasso B; Agostoni A Thromb Haemost; 1992 Nov; 68(5):621. PubMed ID: 1455411 [No Abstract] [Full Text] [Related]
20. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients. Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]